What Are Substance Use Disorders? Signs, Diagnosis, and Treatment

The Language Has Changed — And It Matters

The language used to describe problematic substance use has shifted significantly in clinical practice, and for good reason.

“Addiction” is a common term but carries significant stigma — it is often used to imply that the person is fundamentally flawed or chose their condition. In clinical settings, substance use disorder (SUD) is the preferred term. It is medical, precise, and non-judgmental.

“Substance abuse” is now considered outdated and stigmatizing in clinical contexts — it implies that the person is doing something wrong rather than struggling with a medical condition.

“Dependence” specifically refers to the physiological adaptation to a substance — tolerance and withdrawal — which can occur with many medications even when used exactly as prescribed, without any problematic relationship with the substance.

Language matters because stigma is one of the strongest barriers to treatment-seeking. People who believe they are “addicts” with a character flaw are less likely to seek help than people who understand they have a treatable medical condition.

What Substances Can Cause SUD?

Substance use disorder can involve any substance with abuse potential. The DSM-5 recognizes SUDs for the following substance classes:

• Alcohol — the most prevalent SUD in the US; affects approximately 14.5 million adults annually (SAMHSA, 2023)
• Cannabis — increasingly relevant as potency and prevalence have risen
• Stimulants — cocaine, methamphetamine, prescription amphetamines
• Opioids — heroin, fentanyl, prescription opioids (oxycodone, hydrocodone, morphine)
• Sedatives, hypnotics, and anxiolytics — prescription benzodiazepines (Xanax, Valium, Ativan), Z-drugs (Ambien), barbiturates
• Tobacco/nicotine
• Hallucinogens — LSD, psilocybin, PCP
• Inhalants
• Caffeine (mild, rarely clinically significant)

The same diagnostic criteria apply across all substance classes. The specific risks, withdrawal profiles, and treatment approaches differ substantially by substance.

The DSM-5 Criteria: How SUD Is Diagnosed

The DSM-5 replaced the previous “abuse/dependence” binary with a single diagnosis — substance use disorder — rated mild, moderate, or severe based on how many of 11 criteria are met in a 12-month period.

Impaired control (4 criteria):

1. Using more of the substance or for longer than intended
2. Persistent desire or unsuccessful efforts to cut down or control use
3. Spending a great deal of time obtaining, using, or recovering from the substance
4. Craving — a strong desire or urge to use

Social impairment (3 criteria):

5. Failure to fulfill major role obligations (work, school, home) due to use
6. Continued use despite persistent social or interpersonal problems caused by use
7. Giving up or reducing important activities because of use

Risky use (2 criteria):

8. Using in situations that are physically hazardous (driving, operating machinery)
9. Continued use despite knowing it causes or worsens a physical or psychological problem

Pharmacological criteria (2 criteria):

10. Tolerance — needing more of the substance to achieve the same effect, or noticeably reduced effect with the same amount
11. Withdrawal — characteristic withdrawal symptoms, or using to relieve or avoid withdrawal

Severity ratings:

• Mild SUD: 2–3 criteria
• Moderate SUD: 4–5 criteria
• Severe SUD: 6 or more criteria

Early Warning Signs of Developing SUD

Substance use disorder rarely develops overnight. There is typically a progression from use to problematic use to disorder. Early warning signs — before full SUD criteria are met — are worth recognizing:

• Using more than you planned, more often than intended
• Finding it difficult to keep to self-imposed limits
• Thinking about the substance more than you expected to
• Using in situations where you previously wouldn’t have (alone, early in the day, at work)
• Finding that activities you previously enjoyed feel less appealing without the substance
• Noticing that you need more to get the same effect
• Using to manage emotions — to relax, to cope with stress, to feel normal
• Others expressing concern that you dismiss or minimize

These are not diagnostic criteria — they are signals that a pattern is developing. The earlier intervention occurs in this trajectory, the easier change is.

Screening Tools: Where to Start

Several validated screening tools help identify whether substance use has crossed into problematic territory. The right tool depends on which substance is the concern:

If you’re unsure which substance is the primary concern, the CAGE-AID is the broadest starting point. If you have concerns about both alcohol and drugs, taking the AUDIT and DAST-10 separately gives the most complete picture.

The Neuroscience: Why Substance Use Disorder Is a Brain Condition

Understanding the neuroscience removes the moral framing that stigmatizes SUD and clarifies why willpower alone is usually insufficient for sustained recovery.

The reward pathway: All addictive substances directly or indirectly activate the brain’s mesolimbic dopamine system — the “reward circuit.” This system evolved to reinforce survival behaviors (eating, sex, social bonding). Addictive substances hijack this system, producing dopamine releases 2–10 times greater than natural rewards.

Sensitization and tolerance: With repeated exposure, the reward system adapts. Tolerance develops — more of the substance is needed to produce the same effect. Natural rewards (food, social connection, achievement) become comparatively less rewarding. The brain’s baseline dopamine tone shifts.

The prefrontal cortex: Chronic heavy substance use produces measurable changes in prefrontal cortex function — the brain region responsible for judgment, impulse control, decision-making, and weighing long-term consequences against short-term reward. This is the neurological basis for the compulsive use that characterizes severe SUD: the decision-making machinery is impaired.

Stress systems: Substance use activates stress pathways. In withdrawal, these stress systems are dysregulated — producing anxiety, irritability, and dysphoria that the substance temporarily relieves. This negative reinforcement loop (“using to feel normal”) is as powerful as the positive reinforcement of pleasure.

This neurobiology explains why recovery is a process, not a decision. The brain changes that develop over years of heavy use don’t reverse immediately. They do reverse — neuroplasticity means the brain continues to adapt — but it takes time and support.

SUD and Mental Health: The Co-occurring Condition Reality

The co-occurrence of substance use disorders and mental health conditions is the rule, not the exception:

• Approximately 50% of people with a mental health disorder have a co-occurring SUD (SAMHSA, 2023)
• Approximately 50% of people with SUD have a co-occurring mental health disorder

Common patterns:

Depression and alcohol: Alcohol is a CNS depressant that reliably worsens depression — particularly the days following drinking. Depression also increases risk of heavy drinking. Each makes the other harder to treat if addressed alone.

Anxiety and alcohol/benzodiazepines: Alcohol and benzos provide acute anxiety relief — making them appealing self-medication tools — but worsen anxiety through rebound effects and worsen long-term anxiety course.

PTSD and opioids/alcohol: Trauma survivors use substances to manage hyperarousal, nightmares, and emotional dysphoria at high rates. PTSD and SUD require integrated treatment addressing both.

ADHD and stimulants/cannabis: Undiagnosed or undertreated ADHD creates dopamine dysregulation that drives self-medication with stimulants, cannabis, or other substances.

Effective treatment addresses both the SUD and co-occurring mental health conditions — treating them separately produces worse outcomes than integrated care.

Treatment for Substance Use Disorders

Substance use disorder is highly treatable. Long-term remission rates — defined as no SUD criteria in the past year — reach approximately 50% at 3 years post-treatment and continue to improve with time (NESARC, Kelly et al.).

Behavioral Treatments

Motivational Interviewing (MI): A collaborative, person-centered counseling style that resolves ambivalence about change and builds intrinsic motivation. Effective at every point in the treatment trajectory, from pre-contemplation through relapse prevention.

Cognitive Behavioral Therapy (CBT) for SUD: Targets the thoughts, triggers, and coping patterns that maintain use. Particularly effective for identifying high-risk situations and building skills to navigate them without substances.

Contingency Management: Uses positive reinforcement (rewards for negative drug tests or treatment attendance) to motivate early recovery behaviors. Among the most evidence-based behavioral interventions for stimulant use disorders specifically.

12-Step Facilitation: Structured introduction to 12-step programs (AA, NA) and their community and accountability structures. The social support component of peer recovery communities is a powerful recovery resource.

CRAFT (Community Reinforcement and Family Training): A highly evidence-based program for family members of people with SUD — teaches engagement strategies that are more effective than confrontation or enabling.

Medications

Alcohol use disorder:

• Naltrexone — reduces craving and the rewarding effects of alcohol; available oral or monthly injectable (Vivitrol)
• Acamprosate — reduces protracted withdrawal symptoms; supports abstinence
• Disulfiram — produces aversive reaction if alcohol is consumed; used for motivated patients with good social support
• Gabapentin — emerging evidence for alcohol withdrawal and craving management

Opioid use disorder:

• Buprenorphine (Suboxone, Subutex) — partial opioid agonist; reduces craving and withdrawal; dramatically reduces overdose risk
• Methadone — full opioid agonist dispensed in licensed clinics; gold standard for severe OUD
• Naltrexone — blocks opioid effects; effective for motivated patients after detox

Nicotine use disorder:

• Varenicline (Chantix) — most effective single pharmacotherapy for smoking cessation
• Bupropion — effective and FDA-approved
• NRT (nicotine replacement therapy) — patches, gum, lozenge

Medications for SUD are not “replacing one addiction with another” — this is a persistent stigma-driven misconception. Medications like buprenorphine for OUD restore normal function, prevent overdose death, and are associated with dramatically better long-term outcomes.

Recovery Support

Recovery is a long-term process, not a single treatment episode. Ongoing support structures — peer recovery communities, recovery housing, sober support networks, continuing care — are as important as formal treatment in sustained recovery.

Frequently Asked Questions

Related Tools

Related Guides